Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radiographic image enhancement using iodine-based X-ray absorption refers to the use of iodinated contrast agents to improve the visibility and differentiation of anatomical structures during X-ray-based imaging modalities. Iodine's high atomic number (Z=53) results in strong X-ray absorption, enhancing contrast in CT scans, angiography, and other radiographic procedures. Common agents include iohexol, iodixanol, and ioversol. Safety considerations include allergic reactions and potential nephrotoxicity.
Increased photoelectric absorption of X-rays due to the high atomic number of iodine, leading to enhanced contrast in radiographic images.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radiographic Image Enhancement via Iodine-Based X-ray Absorption.